Effect of Ras-guanine nucleotide release factor 1-mediated H-Ras/ERK signaling pathway on glioma

Yi-Heng Pan1, Jing Chen1, Cui Sun1

  • 1Center for Diagnosis and Treatment of Neuro-oncology Diseases, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China.

Brain Research
|January 7, 2021
PubMed
Abstract

Insights

Ras-guanine nucleotide release factor 1 (Ras-GRF1) is upregulated in glioma and promotes tumor growth and metastasis by activating the H-Ras/ERK pathway. Silencing Ras-GRF1 may suppress glioma progression.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Glioma is a primary brain tumor with poor prognosis.
  • The Ras-guanine nucleotide release factor 1 (Ras-GRF1) role in glioma remains unclear.
  • Understanding signaling pathways involved in glioma is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the function of Ras-guanine nucleotide release factor 1 (Ras-GRF1) in glioma.
  • To elucidate the role of Ras-GRF1 in mediating the H-Ras/ERK signaling pathway in glioma.
  • To explore Ras-GRF1 as a potential therapeutic target for glioma.

Main Methods:

  • Immunohistochemistry was used to detect Ras-GRF1, H-Ras, K-Ras, and N-Ras expression in glioma and normal brain tissues.
  • Glioma cells were transfected with Ras-GRF1 siRNA, H-Ras siRNA, and Ras-GRF1 lentivirus.
  • Cell proliferation, clonogenic ability, migration, invasion, and apoptosis were evaluated using MTT, plate clone formation, wound-healing, Transwell, and Annexin-V/PI assays, respectively.
  • Western blotting measured protein expression, and in vivo studies utilized subcutaneous and orthotopic mouse models.

Main Results:

  • Ras-GRF1, H-Ras, K-Ras, and N-Ras expressions were upregulated in glioma tissues and correlated with WHO grade.
  • Ras-GRF1 expression positively correlated with H-Ras expression.
  • Ras-GRF1 silencing reduced H-Ras and p-ERK/ERK expression, inhibiting glioma cell proliferation, clone formation, migration, and invasion while enhancing apoptosis.
  • In vivo, Ras-GRF1 silencing reduced tumor volume and weight, with decreased H-Ras and p-ERK/ERK levels.

Conclusions:

  • Ras-GRF1 is upregulated in glioma, correlating with malignancy and prognosis.
  • Ras-GRF1 promotes glioma growth and metastasis by mediating the H-Ras/ERK pathway.
  • Targeting Ras-GRF1 may represent a novel therapeutic strategy for glioma.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K